p38 MAPK-dependent phosphorylation of transcription factor SOX2 promotes an adaptive response to BRAF inhibitors in melanoma cells.

MLA

Pietrobono, Silvia, et al. “P38 MAPK-Dependent Phosphorylation of Transcription Factor SOX2 Promotes an Adaptive Response to BRAF Inhibitors in Melanoma Cells.” The Journal of Biological Chemistry, vol. 298, no. 9, Sept. 2022, p. 102353. EBSCOhost, https://doi.org/10.1016/j.jbc.2022.102353.

APA

Pietrobono, S., De Paolo, R., Mangiameli, D., Marranci, A., Battisti, I., Franchin, C., Arrigoni, G., Melisi, D., Poliseno, L., & Stecca, B. (2022). p38 MAPK-dependent phosphorylation of transcription factor SOX2 promotes an adaptive response to BRAF inhibitors in melanoma cells. The Journal of Biological Chemistry, 298(9), 102353. https://doi.org/10.1016/j.jbc.2022.102353

Chicago

Pietrobono, Silvia, Raffaella De Paolo, Domenico Mangiameli, Andrea Marranci, Ilaria Battisti, Cinzia Franchin, Giorgio Arrigoni, Davide Melisi, Laura Poliseno, and Barbara Stecca. 2022. “P38 MAPK-Dependent Phosphorylation of Transcription Factor SOX2 Promotes an Adaptive Response to BRAF Inhibitors in Melanoma Cells.” The Journal of Biological Chemistry 298 (9): 102353. doi:10.1016/j.jbc.2022.102353.